Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
It is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormone pathways instead of one, which is what distinguishes it from single-pathway GLP-1 drugs like semaglutide
If you notice any swelling, severe redness, or burning sensations, discontinue use immediately
If youve started taking a GLP-1 medication, you mightve noticed a few unwelcome side effects along the waylike nausea, fatigue, or even hair loss
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific UK licences: some are approved for type 2 diabetes management (semaglutide [Ozempic], dulaglutide [Trulicity], liraglutide [Victoza]), while others are specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])
January 2010
